BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24931354)

  • 1. Gastroenteropancreatic neuroendocrine (carcinoid) tumors in children.
    Johnson PR
    Semin Pediatr Surg; 2014 Apr; 23(2):91-5. PubMed ID: 24931354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment personalization in gastrointestinal neuroendocrine tumors.
    Borga C; Businello G; Murgioni S; Bergamo F; Martini C; De Carlo E; Trevellin E; Vettor R; Fassan M
    Curr Treat Options Oncol; 2021 Feb; 22(4):29. PubMed ID: 33641005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors.
    Modlin IM; Moss SF; Chung DC; Jensen RT; Snyderwine E
    J Natl Cancer Inst; 2008 Sep; 100(18):1282-9. PubMed ID: 18780869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
    González-Flores E; Serrano R; Sevilla I; Viúdez A; Barriuso J; Benavent M; Capdevila J; Jimenez-Fonseca P; López C; Garcia-Carbonero R
    Clin Transl Oncol; 2019 Jan; 21(1):55-63. PubMed ID: 30535553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management.
    Davis CH; Laird AM; Libutti SK
    Proc (Bayl Univ Med Cent); 2024; 37(1):104-110. PubMed ID: 38174011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS).
    García-Carbonero R; Salazar R; Sevilla I; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):545-51. PubMed ID: 21821488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Diarrhea in Patients With Carcinoid Syndrome.
    Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
    Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study.
    Halperin DM; Shen C; Dasari A; Xu Y; Chu Y; Zhou S; Shih YT; Yao JC
    Lancet Oncol; 2017 Apr; 18(4):525-534. PubMed ID: 28238592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
    Kulke MH; Anthony LB; Bushnell DL; de Herder WW; Goldsmith SJ; Klimstra DS; Marx SJ; Pasieka JL; Pommier RF; Yao JC; Jensen RT;
    Pancreas; 2010 Aug; 39(6):735-52. PubMed ID: 20664472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report.
    Kudelka MR; Abou-Alfa GK; O'Reilly EM; Foote MB; Sirohi B; Elias R; Shamseddine A; Paroder V; Moussa AM; Cohen P; Ganesh K
    J Gastrointest Oncol; 2023 Aug; 14(4):1878-1886. PubMed ID: 37720425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of Prediabetic Hemoglobin A1c (HbA1c) Levels After the Surgical Removal of a Serotonin-Secreting Neuroendocrine Tumor.
    Tskitishvili A; Lobjanidze M; Turmanishvili Z; Mamulashvili N; Bejanishvili T
    Cureus; 2024 Apr; 16(4):e57376. PubMed ID: 38694675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoid-syndrome: recent advances, current status and controversies.
    Ito T; Lee L; Jensen RT
    Curr Opin Endocrinol Diabetes Obes; 2018 Feb; 25(1):22-35. PubMed ID: 29120923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
    Chauhan A; Chan K; Halfdanarson TR; Bellizzi AM; Rindi G; O'Toole D; Ge PS; Jain D; Dasari A; Anaya DA; Bergsland E; Mittra E; Wei AC; Hope TA; Kendi AT; Thomas SM; Flem S; Brierley J; Asare EA; Washington K; Shi C
    CA Cancer J Clin; 2024 Apr; ():. PubMed ID: 38685134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope.
    Giri S; Sahoo J
    World J Gastroenterol; 2024 Mar; 30(12):1670-1675. PubMed ID: 38617746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.
    Cidon EU
    World J Gastrointest Oncol; 2017 Jan; 9(1):4-20. PubMed ID: 28144395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoid Syndrome: A Review.
    Gade AK; Olariu E; Douthit NT
    Cureus; 2020 Mar; 12(3):e7186. PubMed ID: 32257725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine Tumors in Pediatrics.
    Farooqui ZA; Chauhan A
    Glob Pediatr Health; 2019; 6():2333794X19862712. PubMed ID: 31384627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine liver metastases: a contemporary review of treatment strategies.
    Cloyd JM; Ejaz A; Konda B; Makary MS; Pawlik TM
    Hepatobiliary Surg Nutr; 2020 Aug; 9(4):440-451. PubMed ID: 32832495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.
    Fazio N; Ungaro A; Spada F; Cella CA; Pisa E; Barberis M; Grana C; Zerini D; Bertani E; Ribero D; Funicelli L; Bonomo G; Ravizza D; Guarize J; De Marinis F; Petrella F; Del Signore E; Pelosi G; Spaggiari L
    J Thorac Dis; 2017 Nov; 9(Suppl 15):S1501-S1510. PubMed ID: 29201453
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.